Unjust Discrimination Between Cisgender and Transgender Gender-Affirming Care
Authors: Jacob D. Moses, Theodore E. Schall, Lisa Campo-Engelstein
Journal: Annals of Internal Medicine (2023)

Ideas and Opinions4 July 2023Unjust Discrimination Between Cisgender and Transgender Gender-Affirming CareJacob D. Moses, PhD, Theodore E. Schall, MSW, MBE, and Lisa Campo-Engelstein, PhDJacob D. Moses, PhDInstitute for Bioethics and Health Humanities, University of Texas Medical Branch, Galveston, Texas (J.D.M., L.C.), Theodore E. Schall, MSW, MBEBerman Institute of Bioethics and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland (T.E.S.)., and Lisa Campo-Engelstein, PhDInstitute for Bioethics and Health Humanities, University of Texas Medical Branch, Galveston, Texas (J.D.M., L.C.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M23-0704 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In the first months of 2023, more than half the states across the United States sought to prohibit medical care for transgender and gender-diverse (TGD) people. As of May 2023, more than 15 states have passed bills restricting gender-affirming care for TGD youth. For example, Missouri's Senate Bill 49 would strip the license of any clinician providing such care. Lawmakers in Kansas, Oklahoma, and South Carolina have proposed similar penalties for providing care to TGD adults up to age 26 years, suggesting that restrictions initially focused on youth could expand to adults.Such legislation aims to curtail clinicians' authority to ...References1. Engle RL, Bokhour BG, Rose AJ, et al. Characterizing patient attitudes and beliefs towards testosterone therapy in Veterans Affairs: a qualitative study. Patient Educ Couns. 2023;106:201-207. [PMID: 36253229] doi:10.1016/j.pec.2022.10.003 CrossrefMedlineGoogle Scholar2. Soled KRS, Dimant OE, Tanguay J, et al. Interdisciplinary clinicians' attitudes, challenges, and success strategies in providing care to transgender people: a qualitative descriptive study. BMC Health Serv Res. 2022;22:1134. [PMID: 36076288] doi:10.1186/s12913-022-08517-x CrossrefMedlineGoogle Scholar3. Nguyen CP, Hirsch MS, Moeny D, et al. Testosterone and "age-related hypogonadism"—FDA concerns. N Engl J Med. 2015;373:689-91. [PMID: 26287846] doi:10.1056/NEJMp1506632 CrossrefMedlineGoogle Scholar4. James S, Rankin J, Keisling M, et al. The Report of the 2015 U.S. Transgender Survey. National Center for Transgender Equality; 2016. Google Scholar5. Cuccolo NG, Kang CO, Boskey ER, et al. Epidemiologic characteristics and postoperative complications following augmentation mammaplasty: comparison of transgender and cisgender females. Plast Reconstr Surg Glob Open. 2019;7:e2461. doi:10.1097/GOX.0000000000002461 CrossrefGoogle Scholar6. Tolstrup A, Zetner D, Rosenberg J. Outcome measures in gender-confirming chest surgery: a systematic scoping review. Aesthetic Plast Surg. 2020;44:219-228. [PMID: 31664491] doi:10.1007/s00266-019-01523-1 CrossrefMedlineGoogle Scholar7. National Academies of Sciences, Engineering, and Medicine. Understanding the Well-Being of LGBTQI+ Populations. National Academies Pr; 2020 Google Scholar8. Wernick JA, Busa S, Matouk K, et al. A systematic review of the psychological benefits of gender-affirming surgery. Urol Clin North Am. 2019;46:475-486. [PMID: 31582022] doi:10.1016/j.ucl.2019.07.002 CrossrefMedlineGoogle Scholar9. Baker KE, Wilson LM, Sharma R, et al. Hormone therapy, mental health, and quality of life among transgender people: a systematic review. J Endocr Soc. 2021;5:bvab011. [PMID: 33644622] doi:10.1210/jendso/bvab011 CrossrefMedlineGoogle Scholar10. Brummett A, Campo-Engelstein L. Conscientious objection and LGBTQ discrimination in the United States. J Public Health Policy. 2021;42:322-330. [PMID: 33907303] doi:10.1057/s41271-021-00281-2 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Jacob D. Moses, PhD; Theodore E. Schall, MSW, MBE; Lisa Campo-Engelstein, PhDAffiliations: Institute for Bioethics and Health Humanities, University of Texas Medical Branch, Galveston, Texas (J.D.M., L.C.)Berman Institute of Bioethics and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland (T.E.S.).Acknowledgment: The authors thank Arthur Brannon III, MD, PhD, and Lia Boyle, MD, PhD, for their comments on this article.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M23-0704.Corresponding Author: Jacob D. Moses, PhD, Institute for Bioethics and Health Humanities, 301 University Boulevard, Galveston, TX 77555-1311; e-mail, [email protected]edu.Author Contributions: Conception and design: J.D. Moses, T.E. Schall, L. Campo-Engelstein.Drafting of the article: J.D. Moses, T.E. Schall, L. Campo-Engelstein.Critical revision of the article for important intellectual content: J.D. Moses, T.E. Schall, L. Campo-Engelstein.Final approval of the article: J.D. Moses, T.E. Schall, L. Campo-Engelstein.This article was published at Annals.org on 4 July 2023. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics LatestKeywordsBioethicsBreast cancerGender discriminationHormonal therapyHormonesPatient advocacyPlastic surgerySurgeonsSurgeryTestosterone ePublished: 4 July 2023 Copyright & PermissionsCopyright © 2023 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...